Meanwhile, the combined application of chemotherapeutic agents and physcion (a selective 6PGD inhibitor) enhances the efficacy of chemotherapy, suggesting that 6PGD-mediated PPP may play an important role in the occurrence and development of HCC, while also providing a new strategy for combination therapy in HCC (116). This evidence concerns the gene PGD and hepatocellular carcinoma.